-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
In8 Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2024.
- In8 Bio, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$8.56 M, a 13.8% decline year-over-year.
- In8 Bio, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$31.4 M, a 4.93% decline year-over-year.
- In8 Bio, Inc. annual Operating Income (Loss) for 2023 was -$30.3 M, a 6.37% decline from 2022.
- In8 Bio, Inc. annual Operating Income (Loss) for 2022 was -$28.5 M, a 94.6% decline from 2021.
- In8 Bio, Inc. annual Operating Income (Loss) for 2021 was -$14.7 M, a 71.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)